Envista Corp

NVST | NYSE

Price Alert Chart Builder DCF Calculator

$23.43

+$0.08 (+0.34%)

At close: Sep 21, 2026, 4:00 PM ET

$23.50

+$0.07 (+0.30%)

Pre-market: Sep 22, 2026, 8:40 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.34%

(1D)

Rating

Updated: Aug 10, 2026

53.7

Fundamentals Average

Market Sentiment Bullish

Moat Wide

Full Analysis

Key Statistics

Market Data

Market Cap $3.81B

1D Range

23.21 23.69

52W Range

18.77 30.42

Valuation (TTM)

PE 40.40

PB 1,239,383.43

EV/EBITDA 10.85

Valuation (NTM)

Forward PE 13.57

Forward PEG 4.56

Price Target $29.22

Cash Flow

FCF Yield 6.1%

SBC Adj. FCF Yield 5.8%

SBC Impact -5.6%

Margins

Gross Margin 55.5%

Operating Margin 9.9%

FCF Margin 8.1%

Growth (CAGR)

Revenue 3Y | 5Y 3.4% | 3.4%

Dil EPS 3Y | 5Y -22.4% | -16.9%

FCF 3Y | 5Y 13.3% | -11.3%

Returns

ROA 1697307.5%

ROE 4.1%

ROIC 2381972.7%

Financial Health

Net Debt

$310.70

Current Ratio 2.43

Interest Coverage 13.76

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeuti...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 12,000

IPO Date Sep 17, 2019

Website www.envistaco.com

Fiscal Year January - December

Full Company Profile

Latest News

4 days ago · zacks.com

Should Value Investors Buy Envista (NVST) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

4 days ago · zacks.com

Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)

Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

4 days ago · seekingalpha.com

Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript

5 days ago · zacks.com

Here's Why Envista (NVST) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

6 days ago · seekingalpha.com

Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript

13 days ago · zacks.com

NVST or ABT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

14 days ago · prnewswire.com

Envista Announces Participation in Baird 2026 Global Healthcare Conference

BREA, Calif., Sept. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference.